UK charity advancing diabetes care, research, and support
The NHS in England and Wales has approved teplizumab, the first drug that can delay onset of type 1 diabetes. The immunotherapy offers up to three extra years before symptoms require lifelong insulin, with rollout backed by NICE and a commercial deal with Sanofi.
Nice has approved a weekly insulin to reduce injections from 365 to 52, but MHRA approval is pending. The treatment—Onswik, by Eli Lilly—could improve daily life for patients who rely on carers or face dexterity challenges. NHS readiness hinges on regulatory licensing and clear rollout guidelines.
Susan Lumsden has died after an assault at Overstone Lakes in Sywell, Northamptonshire. A 72-year-old man is in custody as police continue their investigation. Family pay tribute to a mother, Nan and friend who loved to make others smile.